Antibiotic-associated encephalopathy

Neurology

Volumn 86, Issue 10, 2016, Pages 963-971

  Bhattacharyya, Shamik ^a,b   Darby, R Ryan ^a,b   Raibagkar, Pooja ^a,b   Castro, L Nicolas Gonzalez ^a,b   Berkowitz, Aaron L ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ISONIAZID; METRONIDAZOLE; OFLOXACIN; PROCAINE PENICILLIN; SULFONAMIDE; CEPHALOSPORIN DERIVATIVE; PENICILLIN DERIVATIVE;

ANTIBIOTIC ASSOCIATED ENCEPHALOPATHY; ANTIBIOTIC THERAPY; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; CEREBELLUM DISEASE; CLINICAL FEATURE; COGNITION; COMORBIDITY; CONSCIOUSNESS; DELIRIUM; DELUSION; DISEASE CLASSIFICATION; DRUG BRAIN LEVEL; DRUG CLEARANCE; DRUG INDUCED DISEASE; EEG ABNORMALITY; ELECTROENCEPHALOGRAM; EXCITOTOXICITY; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; MENTAL HEALTH; MYOCLONUS; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK FACTOR; SEIZURE; TREATMENT DURATION; WERNICKE ENCEPHALOPATHY; BRAIN DISEASES; CASE REPORT; CHEMICALLY INDUCED; FEMALE; MALE; MIDDLE AGED;

ANTI-BACTERIAL AGENTS; BRAIN DISEASES; CEPHALOSPORINS; FEMALE; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PENICILLINS;

EID: 84960540318     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000002455     Document Type: Review

References (54)

1. Inouye SK, Westendorp RGJ, Saczynski JS. Delirium in elderly people. Lancet 2014; 383: 911-922
2. Pompei P, Foreman M, Rudberg MA, Inouye SK, Braund V, Cassel CK. Delirium in hospitalized older persons: outcomes and predictors. J Am Geriatr Soc 1994; 42: 809-815
3. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 2001; 27: 1892-1900
4. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291: 1753-1762
5. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care 2008; 12(suppl 3): S3
6. Inouye SK, Rushing JT, Foreman MD, Palmer RM, Pompei P. Does delirium contribute to Poor hospital outcomes? J Gen Intern Med 1998; 13: 234-242
7. Marcantonio ER, Kiely DK, Simon SE, et al. Outcomes of older people admitted to postacute facilities with delirium. J Am Geriatr Soc 2005; 53: 963-969
8. Abelha FJ, Luís C, Veiga D, et al. Outcome and quality of life in patients with postoperative delirium during an ICU stay following major surgery. Crit Care 2013; 17: R257
9. Lin SM, Liu CY, Wang CH, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med 2004; 32: 2254-2259
10. Leslie DL, Zhang Y, Holford TR, Bogardus ST, Leo-Summers LS, Inouye SK. Premature death associated with delirium at 1-year follow-up. Arch Intern Med 2005; 165: 1657-1662
11. Inouye SK, Bogardus ST, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999; 340: 669-676
12. Fugate JE, Kalimullah EA, Hocker SE, Clark SL, Wijdicks EF, Rabinstein AA. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care 2013; 17: R264
13. Owens RC, Ambrose PG. Antimicrobial safety: focus on fluoroquinolones. Clin Infect Dis 2005; 41(suppl 2): S144-S157
14. Mattappalil A, Mergenhagen KA. Neurotoxicity with antimicrobials in the elderly: a review. Clin Ther 2014; 36: 1489-1511.e4
15. Grill MF, Maganti R. Cephalosporin-induced neurotoxicity: clinical manifestations, potential pathogenic mechanisms, and the role of electroencephalographic monitoring. Ann Pharmacother 2008; 42: 1843-1850
16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245
17. Kuriyama A, Jackson JL, Doi A, Kamiya T. Metronidazoleinduced central nervous system toxicity: a systematic review. Clin Neuropharmacol 2011; 34: 241-247
18. Kim H, Chu K, Jung KH, Lee ST, Kim JM, Lee SK. Acquired encephalopathy associated with carnitine deficiency after cefditoren pivoxil administration. Neurol Sci 2012; 33: 1393-1396
19. Gupta AK, Agarwal MP, Avasthi R, Bhadoria DP, Rohatgi N. Metronidazole-induced neurotoxicity. J Assoc Physicians India 2003; 51: 617-618
20. Fernández-Torre JL, Velasco M, Gutiérrez R, Fernández-Sampedro M. Encephalopathy secondary to imipenem therapy. Clin EEG Neurosci 2004; 35: 100-103
21. Drugs@FDA. FDA Approved Drug Products [Internet]. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2014/050679s031lbl.pdf. Accessed May 24, 2015
22. Lamoth F, Buclin T, Pascual A, et al. High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function. Antimicrob Agents Chemother 2010; 54: 4360-4367
23. Chow KM, Hui AC, Szeto CC. Neurotoxicity induced by beta-lactam antibiotics: from bench to bedside. Eur J Clin Microbiol Infect Dis 2005; 24: 649-653
24. De Sarro A, De Sarro G. Adverse reactions to fluoroquinolones. an overview on mechanistic aspects. Curr Med Chem 2001; 8: 371-384
25. Akahane K, Tsutomi Y, Kimura Y, Kitano Y. Levofloxacin, an optical isomer of ofloxacin, has attenuated epileptogenic activity in mice and inhibitory potency in GABA receptor binding. Chemotherapy 1994; 40: 412-417
26. Akahane K, Sekiguchi M, Une T, Osada Y. Structureepileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1989; 33: 1704-1708
27. Sugimoto M, Fukami S, Kayakiri H, et al. The beta-lactam antibiotics, penicillin-G and cefoselis have different mechanisms and sites of action at GABA(A) receptors. Br J Pharmacol 2002; 135: 427-432
28. Lindquist CEL, Dalziel JE, Cromer BA, Birnir B. Penicillin blocks human alpha 1 beta 1 and alpha 1 beta 1 gamma 2S GABAA channels that open spontaneously. Eur J Pharmacol 2004; 496: 23-32
29. Davidoff RA. Penicillin and inhibition in the cat spinal cord. Brain Res 1972; 45: 638-642
30. Dingledine R, Gjerstad L. Penicillin blocks hippocampal IPSPs, unmasking prolonged EPSPs. Brain Res 1979; 168: 205-209
31. Meyer H, Prince D. Convulsant actions of penicillin: effects on inhibitory mechanisms. Brain Res 1973; 53: 477-482
32. Wong RK, Prince DA. Dendritic mechanisms underlying penicillin-induced epileptiform activity. Science 1979; 204: 1228-1231
33. Van Duijn H, Schwartzkroin PA, Prince DA. Action of penicillin on inhibitory processes in the cat's cortex. Brain Res 1973; 53: 470-476
34. Gutnick MJ, Prince DA. Penicillinase and the convulsant action of penicillin. Neurology 1971; 21: 759-764
35. Sunagawa M, Matsumura H, Sumita Y, Nouda H. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain. J Antibiot (Tokyo) 1995; 48: 408-416
36. Schmuck G, Schürmann A, Schlüter G. Determination of the excitatory potencies of fluoroquinolones in the central nervous system by an in vitro model. Antimicrob Agents Chemother 1998; 42: 1831-1836
37. Thomas RJ, Reagan DR. Association of a Tourette-like syndrome with ofloxacin. Ann Pharmacother 1996; 30: 138-141
38. Hoigne R, Schoch K. Anaphylactic shock and acute nonallergic reactions following procaine-penicillin. Schweiz Med Wochenschr 1959; 89: 1350-1356
39. Graham JH, Maher JR, Robinson SE. The effect of cocaine and other local anesthetics on central dopaminergic neurotransmission. J Pharmacol Exp Ther 1995; 274: 707-717
40. Adinoff B, Devous MD, Cooper DC, Best SE, Harris TS, Williams MJ. Neural Response to Lidocaine in healthy subjects. Psychiatry Res 2009; 173: 135-142
41. Adinoff B, Brady K, Sonne S, Mirabella RF, Kellner CH. Cocaine-like effects of intravenous procaine in cocaine addicts. Addict Biol 1998; 3: 189-196
42. Adinoff B, Devous MD, Best S, George MS, Alexander D, Payne K. SPECT following intravenous procaine in cocaine addiction. Ann NY Acad Sci 1999; 877: 807-810
43. Adinoff B, Devous MD, Best SM, George MS, Alexander D, Payne K. Limbic responsiveness to procaine in cocaine-addicted subjects. Am J Psychiatry 2001; 158: 390-398
44. Kim E, Na DG, Kim EY, Kim JH, Son KR, Chang KH. MR imaging of metronidazole-induced encephalopathy: lesion distribution and diffusion-weighted imaging findings. AJNR Am J Neuroradiol 2007; 28: 1652-1658
45. Rao DN, Mason RP. Generation of nitro radical anions of some 5-nitrofurans, 2-and 5-nitroimidazoles by norepinephrine, dopamine, and serotonin: a possible mechanism for neurotoxicity caused by nitroheterocyclic drugs. J Biol Chem 1987; 262: 11731-11736
46. Alston TA, Abeles RH. Enzymatic conversion of the antibiotic metronidazole to an analog of thiamine. Arch Biochem Biophys 1987; 257: 357-362
47. von Rogulja P, Kovac W, Schmid H. Metronidazole encephalopathy in rats. Acta Neuropathol 1973; 25: 36-45
48. Zuccoli G, Pipitone N, Santa Cruz D. Metronidazoleinduced and Wernicke encephalopathy: two different entities sharing the same metabolic pathway? AJNR Am J Neuroradiol 2008; 29: E84; author reply E85
49. Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol 2009; 192: 501-508
50. Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984; 101: 92-104
51. Weihrauch TR, Köhler H, Höffler D. Cerebral toxicity of penicillins in relation to their hydrophobic character. Naunyn Schmiedebergs Arch Pharmacol 1975; 289: 55-64
52. de Sarro A, Imperatore C, Mastroeni P, de Sarro G. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. J Pharm Pharmacol 1995; 47: 292-296
53. Manian FA, Stone WJ, Alford RH. Adverse antibiotic effects associated with renal insufficiency. Rev Infect Dis 1990; 12: 236-249
54. Chow KM, Szeto CC, Hui ACF, Li PKT. Mechanisms of antibiotic neurotoxicity in renal failure. Int J Antimicrob Agents 2004; 23: 213-217